Uncontrolled warfarin use in elderly patients can lead to diffuse alveolar hemorrhage, a rare but life-threatening complication that requires early diagnosis and drug discontinuation.
DAH may complicate uncontrolled warfarin in elderly patients; case reports leave open incidence and causality.
Diffuse alveolar hemorrhage (DAH) caused by immune and non-immune etiological factors, characterized by diffuse alveolar consolidation, often presents with the clinical triad of dyspnea, hemoptysis and, anemia, as a result of the disruption of the alveolocapillary membrane of the lung. We present four cases, when the patients are over 65 years of age, followed up at our clinic with diffuse alveolar hemorrhage as a rare complication of the uncontrolled use of anticoagulant (Warfarin) therapy.
No takes yet. Share an insight, caveat, or question.
Duru et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: